Furthermore, the Cox proportional hazard model confirmed that dendritic (p = 0.007), CXCL3 (p = 0.014), CXCL5 (p = 0.025), CXCL7 (p = 0.029), CXCL8 (p = 0.025), CXCL11 (p = 0.041), and CXCL17 (p = 0.011) were significantly associated with the clinical outcome of PAAD patients (Table 3). This evidence concerns the gene CXCL5 and pancreatic adenocarcinoma.